CELL SURFACE ANTIGENS--TRANSFERRIN RECEPTORS
细胞表面抗原--转铁蛋白受体
基本信息
- 批准号:2887316
- 负责人:
- 金额:$ 42.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-06-01 至 2001-05-31
- 项目状态:已结题
- 来源:
- 关键词:binding sites biological products cell growth regulation chimeric proteins endocytosis genetic library genetic manipulation human genetic material tag immunochemistry laboratory mouse membrane fusion monoclonal antibody protein structure function protein transport receptor binding receptor expression recombinant proteins tissue /cell culture transfection transferrin transferrin receptor
项目摘要
The long-term goal of this project is to understand the structure-function
relationship of the transferrin receptor and its role in cell growth. The
proposed work will contribute to our appreciation of the molecular basis of
receptor-mediated endocytosis and recycling. It will also contribute to
the evaluation of the transferrin receptor as a potential target for
immunotherapy in the treatment of cancer and the development of more
effective methods of antibody-mediated cell-specific drug targeting. The
specific aims are: 1) to characterize the external domain of the human
transferrin receptor immunochemically and map the transferrin binding site
by structural analysis of chick-human hybrid receptors; 2) to determine
whether the YXRF internalization signal found in the amino-terminal
cytoplasmic domain of the human transferrin receptor is sufficient to
induce rapid endocytosis of other Type II membrane proteins; 3) to express
and isolate sufficient soluble human transferrin receptor external and
cytoplasmic domains for biophysical characterization; 4) to characterize
the interaction of the transferrin receptor cytoplasmic domain with
structural components of coated pits; 5) to investigate the role of the
human transferrin receptor cytoplasmic domain in endosome-endosome fusions;
and 6) to characterize the intracellular compartments through which the
transferrin receptor traffics during endocytosis and recycling.
To achieve these goals, we will use a broad range of experimental methods
derived from molecular biology, protein biochemistry, cell biology, and
immunology. Specifically, we will exploit: 1) the availability of cDNAs
for the human mouse and chicken transferrin receptors; 2) a retroviral
expression system for expressing mutant human transferrin receptors in
chick embryo fibroblasts and analysis of their biological activity; 3)
high-yield protein expression systems in bacteria. Chinese hamster ovary
cells and vaculovirus-infected insect cells that have allowed the
expression of the intact transferrin receptor, and independently, the
cytoplasmic and external domains as soluble recombinant proteins; 4) and
more than 30 monoclonal antibodies against both the external and
cytoplasmic domains of the human transferrin receptor. A major new aspect
of the work is to develop the materials and methods necessary to determine
the 3-dimensional structure of both the cytoplasmic and external domains of
the human transferrin receptor. The former studies will test the validity
of the model we have recently proposed that a Type I turn is the structural
recognition motif for high-efficiency endocytosis.
这个项目的长期目标是了解结构-功能
转铁蛋白受体及其在细胞生长中的作用这个
拟议的工作将有助于我们理解分子基础
受体介导的内吞作用和循环。它还将有助于
转铁蛋白受体作为一种潜在靶点的评价
免疫疗法在癌症治疗中的应用及进展
抗体介导的细胞特异性药物靶向的有效方法。这个
具体目标是:1)描述人类的外部领域
转铁蛋白受体的免疫化学研究及转铁蛋白结合位点的定位
通过对鸡-人杂交受体的结构分析;2)确定
在氨基末端是否发现YXRF内化信号
人转铁蛋白受体的胞浆结构域足以
诱导其他II型膜蛋白的快速内吞;3)表达
并分离出足够量的可溶性人转铁蛋白受体
用于生物物理鉴定的细胞质结构域;4)鉴定
转铁蛋白受体胞质结构域与蛋白质的相互作用
涂层坑的结构组件;5)调查
人转铁蛋白受体胞浆结构域在内体-内体融合中的作用;
和6)表征细胞内的隔室,通过这些隔室
转铁蛋白受体在内吞和循环过程中的交通。
为了实现这些目标,我们将使用广泛的实验方法
源自分子生物学、蛋白质生物化学、细胞生物学和
免疫学。具体地说,我们将利用:1)cDNA的可用性
人、鼠和鸡的转铁蛋白受体;2)逆转录病毒
表达突变型人转铁蛋白受体的表达系统
鸡胚成纤维细胞及其生物学活性分析
细菌中的高产蛋白质表达系统。中国仓鼠卵巢
细胞和空泡病毒感染的昆虫细胞使
完整的转铁蛋白受体的表达,并且独立地,
胞质和外区作为可溶性重组蛋白;4)和
30多种针对外部和外部的单抗
人转铁蛋白受体的胞质结构域。一个重大的新方面
工作的重点是开发必要的材料和方法来确定
胞质和胞外结构域的三维结构
人类转铁蛋白受体。以前的研究将检验效度
在我们最近提出的模型中,第一类转向是结构
高效内吞作用的识别基序。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IAN S TROWBRIDGE其他文献
IAN S TROWBRIDGE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IAN S TROWBRIDGE', 18)}}的其他基金
ANTITUMOR THERAPY WIH ANTITRANSFERRIN RECEPTOR MONOCLONAL ANTIBODIES
使用抗转铁蛋白受体单克隆抗体的抗肿瘤治疗
- 批准号:
6102191 - 财政年份:1997
- 资助金额:
$ 42.45万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 42.45万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 42.45万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 42.45万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 42.45万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 42.45万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 42.45万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 42.45万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 42.45万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 42.45万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 42.45万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)